Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

International Endeavors Corp. Now Offers Customer Financing for Lease/Purchase of Off Grid Grow Lab


Posted on: 18 Jun 18

TEMECULA, Calif., June 18, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- International Endeavors Corp (OTC:IDVV) is pleased to announce that for customers who qualify, financing is now available for the purchase or leasing of the Off Grid Grow Lab (“OGGL”). International Endeavors Corp. helps customers to obtain loans directly from banks, alternative lending sources, the Farm Service Agency of the United States Department of Agriculture (USDA), and loans guaranteed by the Small Business Administration.

The USDA also has a microloan program that supports the needs of the small, beginning farmer, niche and non-traditional farm operations, such as farms participating in direct marketing and sales to farmers’ markets, restaurants, grocery stores, and those using hydroponic, aquaponic, organic, and vertical-growing methods.

Third-party lenders, such as banks, give customers loans for the OGGL because it is categorized as new farming equipment. Alternative financing may also be available. International Endeavors’ Marketing Director, William Vinson, said, “Financing helps customers start growing operations with lower initial capital investment. Since the OGGL uses solar power, the operational costs are much less, which makes it easier to have profitable results faster.”

About the OGGL: The OGGL is the first purpose built self-contained off grid growing laboratory. Built around low cost shipping containers the OGGL ships with integrated solar modules and lithium phosphate batteries coupled with generator backup for 24-hour power to the grow. The OGGL has been configured for the three stages of growing, which include, vegetative, flowering, and cloning.

Off Grid Grow Lab Video
https://drive.google.com/file/d/1f7TnB45Iipbz1rrrrnTyFsGVjYym82ms/view

About International Endeavors Corporation
International Endeavors Corporation is a company focused on building IP in the Medical Marijuana and Legal Cannabis Industry through the creation of Biomedical Devices, Clean Energy Solutions and Patents. (IEC) is also engaged in locating and acquiring established companies, brands and technologies. The Companies portfolio includes commercial and agricultural land and buildings.

Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and other similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. International Endeavors Corporation (IDVV) is under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.

Contact:
Nate Engel, CEO Phone: 951-296-1024
Email: nate@internationalendeavorscorp.com
William Vinson, Marketing Director
702-473-4477 

Source: International Endeavors Corporation

GlobeNewswire
globenewswire.com

Last updated on: 18/06/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.